Gregory S. Raskin, Director at Y-mAbs Therapeutics, Inc. (YMAB), sold 11,764 shares at $26.70 ($314K) on 2019-08-29, disclosed to the SEC on 2019-08-29.
Open-market sale of $314k YMAB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.70 | 5,882 | $157K | 50.0% |
| 2 | $26.70 | 5,882 | $157K | 50.0% |
| Total | $26.70 avg | 11,764 | $314K | 100% |